Gynecologic Cancers
Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer
January 27, 2023
Video
Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Greatest Unmet Needs for Patients with Endometrial Cancer
January 27, 2023
Video
The panel shares the most critical unmet needs for patients with endometrial cancer.
Children Exposed to Maternal Cancer Show Normal Cognitive and Behavioral Outcomes
January 24, 2023
Article
An analysis of 141 children who had prenatal exposure to maternal cancer showed promising cognitive and behavioral functions at age 9 years.
Nurses Must Stay Up-to-Date With Treatments and Clinical Trials for Patients With Cervical Cancer
January 23, 2023
Article
January is cervical cancer awareness month. This third article in a series highlights current cervical cancer treatment options.
Discussing Dose Reductions and Interruptions with Patients on Therapy for Endometrial Cancer
January 20, 2023
Video
Kimberly A. Spickes, CNP, discusses how often patients with endometrial cancer have dose reductions or interruptions at her institution, and who is involved in the decision to dose-reduce.
Proactive Adverse Effect Management for Patients on Therapy for Endometrial Cancer
January 20, 2023
Video
Nurse Practitioner Kimberly Halla explains the proactive measures she takes to ensure patients with endometrial cancer are prepared to experience and manage the adverse effects of treatment.
Opinion: Oncology Nurses Require an Understanding of Cervical Cancer Testing and Screening
January 19, 2023
Article
January is cervical cancer awareness month. This second article in a series highlights current cervical screening guidelines.
Triplet Regimen of COM701, BMS-986207, and Nivolumab Shows Antitumor Activity in Platinum-Resistant Ovarian Cancer
January 15, 2023
Article
Patients with heavily pretreated, platinum-resistant ovarian cancer showed promising responses with a triplet regimen consisting of COM701, BMS-986207, and nivolumab.
Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer
January 13, 2023
Video
Kimberly A. Spickes, CNP, details the adverse events she sees with combination lenvatinib and pembrolizumab treatment for recurrent endometrial cancer.
Monitoring Patients on Therapy for Recurrent Endometrial Cancer
January 13, 2023
Video
Kimberly Halla, NP, describes the standards for monitoring patients on therapy for recurrent endometrial cancer, including how often patients are seen in-person.